Clinical and genetic factors associated with increased risk of severe liver toxicity in a monocentric cohort of HIV positive patients receiving nevirapine-based antiretroviral therapy
Abstract Background Nevirapine has been used as antiretroviral agent since early ‘90. Although nevirapine is not currently recommended in initial anti-HIV regimens, its use remains consistent in a certain number of HIV-1-positive subjects. Thus, our aim was to determine clinical and genetic factors...
Main Authors: | Andrea Giacomelli, Agostino Riva, Felicia Stefania Falvella, Maria Letizia Oreni, Dario Cattaneo, Stefania Cheli, Giulia Renisi, Valentina Di Cristo, Angelica Lupo, Emilio Clementi, Stefano Rusconi, Massimo Galli, Anna Lisa Ridolfo |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-11-01
|
Series: | BMC Infectious Diseases |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12879-018-3462-5 |
Similar Items
-
Nevirapine-induced side effects in pregnant women: experience of a brazilian university hospital
by: William Kondo, et al. -
Clinical and genetic determinants of nevirapine plasma trough concentration
by: Andrea Giacomelli, et al.
Published: (2018-06-01) -
Nevirapine induced toxic epidermal necrolysis and non-Hodgkin lymphoma in a Human Immunodeficiency Virus positive patient
by: Leelavathy Budamakuntla, et al.
Published: (2014-01-01) -
Formulation of a nevirapine co-crystal as a liquid dosage form
by: Injety, Sahana
Published: (2016) -
Rapid Determination of Nevirapine in Human Plasma by High- Performance Liquid Chromatography
by: Kantima Sangsiriwut, et al.
Published: (2007-01-01)